Skip to content
healthcare.dev

cisatracurium besylate

NDC 70710-1532, cisatracurium besylate, injection, from Zydus Pharmaceuticals USA Inc..

Product NDC
70710-1532
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212171
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1532 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CISATRACURIUM BESYLATE2 mg/mL

Pharmacologic classes

Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
70710-1532-67071015320610 VIAL in 1 CARTON (70710-1532-6) / 5 mL in 1 VIAL (70710-1532-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f9e1a84b-d19e-46c5-b40f-944ac1543dac

Use it

Look up 70710-1532 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1532 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-1532. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.